A study published in August 2026 in the journal Scientific Reports raises new questions about the long-term immunological effects of repeated COVID-19 mRNA vaccinations. Researchers observed a sustained shift in the antibody response toward the IgG4 class in adults and children. Particularly noteworthy: In a group of adults studied, a higher IgG4 proportion was associated with an increased risk of later SARS-CoV-2 breakthrough infections.
The study, published on August 12, 2026, examined the immune responses of 104 Swedish healthcare workers who had received five to six mRNA vaccinations. Additionally, the scientists analyzed blood samples from 18 children in Singapore after two to three vaccinations.
The focus was on how repeated vaccinations affect the composition and properties of antibodies targeting the spike protein in the long term.
The results show that repeated administration of mRNA vaccines not only affects the amount of antibodies but also alters their composition.
The striking shift to IgG4
Normally, the early antibody response against the spike protein is primarily shaped by IgG1. These antibodies, in addition to their ability to detect the virus, can activate various immune defense mechanisms.
IgG4, on the other hand, has different properties. It activates certain pro-inflammatory defense mechanisms much more weakly and is often associated with immunological adaptation to repeated or prolonged antigen contacts.
This exact shift was observed by the researchers after repeated mRNA vaccinations.
Among participants who had not had a SARS-CoV-2 infection before their first vaccination, the average proportion of spike-specific IgG4 antibodies after the sixth vaccination temporarily reached 26.8 percent. Individual participants even showed values of up to 75 percent.
The duration of this effect is particularly relevant: the altered antibody composition persisted over several vaccinations during the course of the study. The scientists followed the adult cohort over a total of five years.
This does not mean that all immune system antibodies have been replaced by IgG4. The observed change concerns the specific immune response against the spike protein. Nevertheless, it is a clear and lasting immunological adaptation.
Higher IgG4 levels associated with breakthrough infections
Another finding concerns the question of whether this antibody shift could have practical consequences for infection protection.
To do this, the researchers examined a subgroup of 41 adults who had received three vaccinations and had not yet been infected with SARS-CoV-2 at the time of the study.
In these individuals, a statistical correlation was found between the IgG4 content and the risk of a later breakthrough infection.
The scientists determined a hazard ratio of 1.83 per standard deviation with a higher IgG4 content. Simply put, a higher IgG4 proportion within this group was associated with an increased risk of later infection.
However, the study does not yet prove that IgG4 itself causes the infections. This would require larger studies and direct investigations of the underlying immune mechanisms.
What remains striking, however, is that the researchers not only documented a change in antibody composition but also found a connection to a specific health event.
The breakthrough infections observed in this group were asymptomatic or mild.
Previous infection made a clear difference
The influence of individual immunity history is particularly interesting.
The researchers distinguished between people who had been vaccinated first and those who had already had a SARS-CoV-2 infection before their first vaccination.
In the first group, the IgG4 shift was significantly stronger.
In contrast, people with a prior infection developed on average lower IgG4 levels. A comparable, statistically significant increase across multiple vaccinations was not observed in this group.
The scientists therefore suspect that the first encounter of the immune system with the virus or its spike protein may influence how it responds to later vaccinations in the long term.
This brings a question to the forefront that was often only marginally discussed during vaccination campaigns: What significance does the sequence of natural infection and vaccination have for the long-term quality of the immune response?
The study provides indications that this sequence is immunologically relevant. However, it does not conclusively answer which vaccination strategy is the most cost-effective for individual population groups in the long term.
Also observed in children
The scientists observed similar changes in a smaller group of children from Singapore.
The 18 children studied were between five and twelve years old and had received two to three doses of an mRNA vaccine. Changes in IgG subclasses and certain antibody properties similar to those of adult participants were also observed in them.
However, due to the small number of participants, the researchers were unable to investigate whether there is also a link between elevated IgG4 and later breakthrough infections in children.
Nevertheless, the observation shows that antibody shift does not occur exclusively in adults.
What are the consequences of the altered immune response?
The crucial question concerns the function of these IgG4 antibodies.
IgG4 can still recognize pathogens or their components. However, certain additional defense functions, such as activation of the complement system or cooperation with various immune cells, are less pronounced than in other IgG subclasses.
A stronger IgG4 response could theoretically influence how the body responds to later contact with SARS-CoV-2.
The researchers also discuss changes in so-called Fc glycosylation. These are chemical structures of antibodies that influence their interaction with immune cells.
Here too, they found long-term differences between people with and without prior infection.
Whether these changes actually lead to reduced immune defense or are compensated by other components of the immune system remains open. The study provides indications on this but does not provide conclusive proof of function.
Five years of observation – many questions remain
The study is particularly interesting because of its long observation period and repeated blood samples. In total, the researchers analyzed 831 samples from the adult participants.
This allowed them to track how the antibody response evolved across multiple vaccinations and infection events.
At the same time, the investigation has its limits. The analysis of breakthrough infection risk included only 41 adults, excluding women. Additionally, differences in virus variants, infection contacts, and timing of vaccination may have influenced the results.
The authors therefore explicitly state that the clinical significance of this IgG4 shift has not yet been conclusively clarified.
They also emphasize that the proven protection of mRNA vaccines against severe COVID-19 cases is not contradicted by their results.
What does this mean for the repeated vaccination recommendations?
The study shows that repeated mRNA vaccinations can trigger a lasting change in the specific immune response, the long-term consequences of which are not yet fully understood.
Noteworthy is the combination of three observations: the IgG4 shift remained detectable over several years, was particularly pronounced in people without prior infection, and within a subgroup studied, a higher IgG4 proportion was associated with an increased risk of breakthrough infections.
This raises the question of whether, in addition to the level of neutralizing antibodies, repeated booster vaccinations will need to be given greater consideration in the future to which antibody classes are formed and how well they actually contribute to virus defense.
The results are not evidence of general immune system damage caused by mRNA vaccines. However, they make it clear that the long-term assessment of repeated vaccinations should not be based solely on antibody levels.
